A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease
Not yet recruiting · NCT07838155 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Phase 4 | 2026-09-24 | NCT07838155 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Apollo Multispeciality Hospitals limited | Kolkata | India | 3 |
| Apollo Speciality Hospital - Teynampet | Tamil Nadu | India | 1 |
| Aster CMI Hospital | Bangalore | India | 1 |
| Christian Medical College Vellore | Vellore | India | 1 |
| Indraprastha Apollo Hospital | New Delhi | India | 1 |
| Institute of Human Behaviour and Allied Sciences | New Delhi | India | 1 |
| Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute | Mumbai | India | 1 |
| Manipal Hospital | Bangalore | India | 1 |
| NIMHANS | Bangalore | India | 1 |